发明名称 METHOD FOR BLOOD MICROVESCILE LEVEL CORRECTION IN ARTERIAL HYPERTENSION, ABDOMINAL OBESITY AND IMPAIRED GLUCOSE TOLERANCE
摘要 FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, namely to haematology, cardiology and endocrinology, and concerns normalisation of the blood microvesicle level in arterial hypertension, abdominal obesity and impaired glucose tolerance. That is ensured by the administration of Irbesartan 150 mg once in the morning combined with Metformin 500 mg twice a day. In addition, the patients perform graduated physical activity, including morning hygienic gymnastics, therapeutic gymnastics and graduated physical exercises throughout a day. The length of treatment is at least 5 weeks. ^ EFFECT: method ensures the correction of the blood microvesicle level in the case patients, and consequently, reduced risk of thrombotic complications, such as infarction and stroke. ^ 1 ex
申请公布号 RU2400228(C1) 申请公布日期 2010.09.27
申请号 RU20090114678 申请日期 2009.04.17
申请人 MEDVEDEV IL'JA NIKOLAEVICH;BESPARTOCHNYJ BORIS DMITRIEVICH 发明人 MEDVEDEV IL'JA NIKOLAEVICH;ZAVALISHINA SVETLANA JUR'EVNA;KRASNOVA EVGENIJA GENNADIEVNA;BESPARTOCHNYJ BORIS DMITRIEVICH
分类号 A23L33/00;A61H1/00;A61K31/175;A61K31/4155;A61P3/10;A61P9/12 主分类号 A23L33/00
代理机构 代理人
主权项
地址